Ido Lubin
Petah Tiqwa, M 49414, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Hepatitis B Virus-Induced Resistance to Sorafenib and Lenvatinib in Hepatocellular Carcinoma Cells: Implications for Cell Viability and Signaling Pathways.
Journal: Cancers
Published: September 29, 2024
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor.
Journal: Oncoimmunology
Published: August 18, 2023
mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy.
Journal: Cancers
Published: June 15, 2023
A novel role for an old target: CD45 for breast cancer immunotherapy.
Journal: Oncoimmunology
Published: June 09, 2021
Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species- and GSK3β-dependent mechanism.
Journal: British journal of haematology
Published: July 15, 2020
Synergistic cytotoxic activity of cannabinoids from cannabis sativa against cutaneous T-cell lymphoma (CTCL) in-vitro and ex-vivo.
Journal: Oncotarget
Published: July 15, 2019
GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment.
Journal: BMC cancer
Published: May 12, 2019
Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38- cells through iron chelation, induction of ROS, and inhibition of HIF1α expression.
Journal: Experimental hematology
Published: April 24, 2018
Oncogenic role of microRNA-155 in mycosis fungoides: an in vitro and xenograft mouse model study.
Journal: The British journal of dermatology
Published: February 23, 2017
Ponatinib reduces viability, migration, and functionality of human endothelial cells.
Journal: Leukemia & lymphoma
Published: October 14, 2016
Bi-functional prodrugs of 5-aminolevulinic acid and butyric acid increase erythropoiesis in anemic mice in an erythropoietin-independent manner.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: March 15, 2016
The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.
Journal: PloS one
Published: August 19, 2015
Last Updated: 09/26/2026